Back to Search Start Over

Atalanta loads crossbow with $97M, targeting neuro trial starts for 2 RNAi therapies.

Authors :
Masson, Gabrielle
Source :
FierceBiotech; 1/28/2025, pN.PAG-N.PAG, 1p
Publication Year :
2025

Abstract

Atalanta Therapeutics has bagged $97 million, funds that will go toward starting clinical trials for epilepsy and Huntington's disease candidates. [ABSTRACT FROM AUTHOR]

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
182535423

Tools

Authors Abstract Subjects Details